User profiles for Sebastien Hapdey

Sébastien Hapdey

Centre Henri Becquerel, Rouen
Verified email at chb.unicancer.fr
Cited by 1579

[HTML][HTML] Management of respiratory motion in PET/computed tomography: the state of the art

A Pepin, J Daouk, P Bailly, S Hapdey… - Nuclear medicine …, 2014 - journals.lww.com
Combined PET/computed tomography (CT) is of value in cancer diagnosis, follow-up, and
treatment planning. For cancers located in the thorax or abdomen, the patient’s breathing …

Development of a generic thresholding algorithm for the delineation of 18FDG-PET-positive tissue: application to the comparison of three thresholding models

S Vauclin, K Doyeux, S Hapdey… - Physics in Medicine …, 2009 - iopscience.iop.org
An iterative generic algorithm has been developed to compare three thresholding models
used to delineate gross tumour volume on 18 F-FDG PET images. 3D volume was extracted …

Simultaneous positron emission tomography (PET) assessment of metabolism with 18F-fluoro-2-deoxy-d-glucose (FDG), proliferation with 18F-fluoro-thymidine (FLT) …

…, P Bohn, A Edet-Sanson, A Salles, S Hapdey… - Radiotherapy and …, 2011 - Elsevier
OBJECTIVES: To investigate the changes in tumour proliferation (using FLT), metabolism (using
FDG), and hypoxia (using F-miso) during curative (chemo-) radiotherapy (RT) in …

Comparative assessment of methods for estimating tumor volume and standardized uptake value in 18F-FDG PET

…, S Stute, N Grotus, K Doyeux, S Hapdey… - Journal of nuclear …, 2010 - Soc Nuclear Med
In 18 F-FDG PET, tumors are often characterized by their metabolically active volume and
standardized uptake value (SUV). However, many approaches have been proposed to …

Phase II study of a radiotherapy total dose increase in hypoxic lesions identified by 18F-misonidazole PET/CT in patients with non–small cell lung carcinoma (RTEP5 …

…, P Bohn, M Vermandel, S Hapdey… - Journal of Nuclear …, 2017 - Soc Nuclear Med
See an invited perspective on this article on page 1043 . This multicenter phase II study
investigated a selective radiotherapy dose increase to tumor areas with significant 18 F-…

Baseline total metabolic tumor volume measured with fixed or different adaptive thresholding methods equally predicts outcome in peripheral T cell lymphoma

AS Cottereau, S Hapdey, L Chartier… - Journal of Nuclear …, 2017 - Soc Nuclear Med
The purpose of this study was to compare in a large series of peripheral T cell lymphoma, as
a model of diffuse disease, the prognostic value of baseline total metabolic tumor volume (…

Quantitative accuracy of dopaminergic neurotransmission imaging with 123I SPECT

…, PM Koulibaly, J Darcourt, S Hapdey… - Journal of Nuclear …, 2003 - Soc Nuclear Med
123 I-Labeled radiotracers are suitable for in vivo imaging of the dopaminergic system by
SPECT. However, precise measurement of striatal uptake is limited by scatter, attenuation, and …

Radiotherapy boost in patients with hypoxic lesions identified by 18F-FMISO PET/CT in non-small-cell lung carcinoma: can we expect a better survival outcome …

…, R Modzelewski, P Bohn, S Hapdey… - European Journal of …, 2019 - Springer
Radiotherapy boost in patients with hypoxic lesions identified by 18F-FMISO PET/CT in non-small-cell
lung carcinoma: can we expect a better survival outcome without toxicity? [RTEP5 …

[HTML][HTML] FDG and FMISO PET-guided dose escalation with intensity-modulated radiotherapy in lung cancer

…, B Dubray, R Modzelewski, P Bohn, S Hapdey… - Radiation …, 2018 - Springer
Background Concomitant chemo-radiotherapy is the reference treatment for non-resectable
locally-advanced Non-Small Cell Lung Cancer (NSCLC). Increasing radiotherapy total dose …

Serial assessment of FDG-PET FDG uptake and functional volume during radiotherapy (RT) in patients with non-small cell lung cancer (NSCLC)

…, B Dubray, K Doyeux, A Back, S Hapdey… - Radiotherapy and …, 2012 - Elsevier
OBJECTIVES: The objectives were (i) to confirm that diagnostic FDG-PET images could be
obtained during thoracic radiotherapy, (ii) to verify that significant changes in FDG uptake or …